Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep284 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Factors affecting glycemic outcomes using closed-loop systems in real-world

Fabregas Lara Albert , Andujar David Subias , Gregori Ana Romero , Luchtenberg Maria Florencia , Palomares Albert Cano , Mazarico Isabel , Rigla Mercedes

Aims: To evaluate real-world efficacy of closed-loop systems (CLS) (MinimedTM 780G, DBLG1 -Diabeloop- and Control-IQTM Tandem) as well as to assess those predictive factors related with the achievement of near-normal glycemic control.Methods: A prospective, longitudinal, and observational study was performed. It included T1D adults who initiated CLS between April and December 2021 in our hospital and provided data for ≧3 months (...

ea0081ep1081 | Thyroid | ECE2022

Thyrotoxic crisis presented as psychiatric decompensation

Martins Ferreira Mafalda , Araujo Catia , Lavrador Mariana , Guiomar Joana Reis , Oliveira Patri cia , Moreno Carolina , Paiva Isabel

Introduction: Thyrotoxic crisis is a rare endocrinological emergency with high mortality and it is more frequent in Graves’ disease.Clinical case: A 66-year-old women with schizophrenia was admitted to the Emergency Department due to altered state of consciousness, fatigue, constant moaning interspersed with unusual psychomotor agitation, heteroaggressiveness, diarrhea and anorexia. Lack of compliance with her psychiatric medication, new delusional ...

ea0085oc6.3 | Oral Communications 6 | BSPED2022

Use of 24 weekly decapeptyl SR in central precocious puberty is well-tolerated and efficacious – a two centre study

Lake Lydia , Kothayan Bharathy , Sharratt Isabel , O'Sullivan Jacquelin , Russell Julia , Sharma Veena , Cheetham Tim , Wood Claire , Howard Sasha

Central precocious puberty (CPP) is a common and well-recognised condition characterised by premature activation of the hypothalamic-pituitary-gonadal axis, with consequent potential adverse health and psychosocial outcomes. Standard management of CPP is with periodic injections of gonadotropin-releasing hormone analogue therapy. Decapeptyl SR (Triptorelin pamoate) has for several years been available as a long-acting (12-weekly, 11.25 mg) preparation, but more recently is ava...

ea0090p144 | Pituitary and Neuroendocrinology | ECE2023

Glucocorticoid Resistance Syndrome: a Rare Disorder that we Must not Forget. A Clinical Case

Martin Timon Iciar , Moreno-Ruiz Inmaculada , Meizoso-Pita Olalla , Huguet Isabel , Llavero Valero Maria , Trivino Yannuzzi Vanessa , Sevillano-Collantes Cristina

Primary generalized glucocorticoid resistance or Chrousos syndrome is a rare disorder, which affects all tissues expressing the human glucocorticoid receptor. It has been defined by an absence of overt Cushing’s syndrome (CS) signs (no skin weakness, muscle atrophy, or osteoporosis) associated with biological hypercortisolism consisting of high urinary free cortisol (UFC) and an absence of negative feedback loop of cortisol on HPA, defined as 8-AM cortisol level >50 n...

ea0090p261 | Late-Breaking | ECE2023

Factored aldosterone can help distinguish mineralocorticoid resistance from aldosterone deficit hypoaldosteronism

Gabriel Ruiz Sanchez Jorge , Calle Alfonso , Angel Rubio Herrera Miguel , Paz de Miguel Novoa Maria , Gomez Hoyos Emilia , Runkle Isabel

Introduction: Hypoaldosteronism can be induced by a deficit of aldosterone production (AldDef) or a mineralocorticoid resistance (MinRes). Experts have proposed to use hyperkalemia-based aldosterone values for this purpose. However, there is no a range of aldosterone values indicating one of this type of hypoaldosteronism. In 2008, Adam W. R.1 hypothesized that the factored aldosterone (FAldo) could be useful differentiating hypoaldosteronism secondary to MinRes fro...

ea0090ep665 | Environmental Endocrinology | ECE2023

Psychosocial profile of transgender population attended in a gender identity unit

Toscano Esteban Sanchez , Zayas Aguilar Irene , Mateo Gavira Isabel , Larran Escandon Laura , Vega Trujillo Lopez Maria de la

Introduction: Transgender people are a diverse population affected by a variety of negative health indicators. Studies report, among other conditions, a high prevalence of mental health problems and substance abuse. However, there are still health issues that have been poorly analyzed and long-term longitudinal follow-up studies are scarce.Objective: The aim of this study is to deep into the demographic characteristics and the psychosocial profile of tra...

ea0090ep1123 | Late Breaking | ECE2023

Trends in Prescription of Anti-Diabetic Drugs and Metabolic Control in Type 2 Diabetes: 2015/2016 vs. 2020/2021

Soares Daniela , Palma Isabel , Helena Neto Maria , Fraga Mariana , Pereira Joel , Guimaraes Rosa , Helena Cardoso Maria , Maia Ariana , Ferreira Lia

Introduction: The development of new pharmacological classes for type 2 diabetes (T2D) treatment with extra-glycaemic benefits has led to the update of the treatment algorithm, presenting new effective alternatives to patients’ insulinization. The present study aims to evaluate the evolution of prescription and its impact in metabolic control of patients enrolled on an educational diabetes program of a tertiary hospital.Objectives: To evaluate trend...

ea0063gp100 | Adrenal and Neuroendocrine - Basic | ECE2019

Characterization of cell death induced by mitotane in adrenocortical carcinoma cells

Weigand Isabel , Schreiner Jochen , Rohrig Florian , Kiseljak-Vassiliades Katja , Hofner Kerstin , Kendl Sabine , Fassnacht Martin , Sbiera Silviu , Kroiss Matthias

Background: Mitotane is the only drug approved for treatment of adrenocortical carcinoma (ACC). We have found that mitotane leads to endoplasmic reticulum stress and decreased viability in ACC cells. It is not known by which downstream mechanisms cell death is induced by mitotane.Aim: To characterize the mechanisms underlying cell death resulting from mitotane treatment in ACC cells.Methods: Lipid peroxidation in the ACC cell line ...

ea0063p165 | Diabetes, Obesity and Metabolism 1 | ECE2019

Results at 2 years of bariatric surgery in patients with type 2 diabetes mellitus

Medina Rivero Daniel , Maria Mateo Gavira Isabel , Lara Barea Almudena , Angeles Mayo Ossorio Maria , Aguilar Diosdado Manuel

Objectives: 1. To evaluate the effect after two years of bariatric surgery on comorbidities in patients with diabetes mellitus type 2 (DMT2) and obesity grade II or higher.2. Analyze the surgical complications in these patients.Material and methods: Cohort study with intrasubject measures (before-after) in patients with grade II or higher obesity and T2DM, who underwent bariatric surgery (gastric bypass or vertical gastrectomy) at ...

ea0063p181 | Diabetes, Obesity and Metabolism 1 | ECE2019

Gestational diabetes mellitus and continuous glucose monitoring: glycemic patterns and pregnancy outcomes

Rosa Marquez-Pardo , Isabel Torres-Barea , Doncel Lourdes Garcia-Garcia , Concepcion Cruzado-Begines , Maria-Gloria Baena-Nieto

Introduction: Gestational diabetes mellitus (GDM) is associated with an increase risk of neonatal and maternal complications. Continuous glucose monitoring (CGM) detects glycemic patterns, which could help predict the development of maternal-fetal complications.Objective: To analyze the different glycemic patterns obtained with CGM and to correlate them with the appearance of maternal-fetal complications in GDM.Methods: Women with ...